The methods, devices and systems described herein relate to accessing a hollow organ. In one example, they relate to improved and safer delivery devices and methods for performing a transseptal crossing into the left atrium from the right atrium across an atrial septal wall.
By nature of their location, accessing and treating internal tissues and/organs is inherently difficult. Invasive surgery introduces a high level of risk that can result in serious complications for the patient. Access to the organ remotely with a catheter or equivalent device is less risky, but a desired treatment is made more difficult given the limited physical abilities of the catheter. This difficulty is compounded when the targeted treatment site is found in or near a vital organ, such as the heart.
A human heart includes a right ventricle, a right atrium, a left ventricle and a left atrium. The atria and ventricles are each separated by a septal wall. The fossa ovalis is a thin, distensible portion of the atrial septal wall. Because the right atrium is in fluid communication with the superior vena cava and the inferior vena cava, it is relatively accessible intravenously. Access to the left atrium (and ventricles) is more difficult and typically requires traversing the aortic arch and aortic valve. Therefore, access to the left atrium is commonly obtained using a transseptal procedure, which usually requires puncturing the atrial septal wall.
The transseptal approach for left atrial or ventricular access has been known in the art for some time and can be used in a variety of procedures such as percutaneous balloon mitral valvuloplasty, antegrade percutaneous aortic valvuloplasty as well as catheter ablation of arrhythmias arising from the left atrium or utilizing left sided bypass tracts. The transseptal approach is typically used to cross from the right atrium to the left atrium through the fossa ovalis. In a transseptal procedure, a needle and catheter are generally used to puncture the atrial septal wall at the fossa ovalis.
In a typical transseptal procedure, a guidewire is first inserted through the right femoral vein and advanced to the superior vena cava. Sometimes, a sheath is placed over a dilator that is advanced over the guidewire into the superior vena cava. The guidewire is then removed and a puncture device, such as a Brockenbrough needle, is advanced up to the dilator tip. The apparatus is dragged down, pushed up, or a combination of both as necessary into the right atrium, along the septum. When the dilator tip is positioned adjacent the fossa ovalis (sometimes determined under ultrasound, fluoroscopic, or other guidance), the needle is then advanced forward so that it extends past the dilator tip, through the fossa ovalis into the left atrium. The dilator and sheath may then be advanced through the fossa ovalis over the needle. The dilator and needle are then removed, leaving the sheath in place in the left atrium. Thereafter, a guidewire or catheter may be inserted into the left atrium (through the sheath) in order to perform the desired procedure. Additional techniques may be used to determine position such as biplane fluoroscopy, pressure manometry, contrast infusion, transesophageal or intracardiac echocardiography.
Current techniques for transseptal approach come with a relatively high degree of risk that the transseptal puncture device will damage tissue near the septal wall, such as the aorta, the coronary sinus or the far wall of the atrium. Accordingly, improved systems and methods for performing a transseptal crossing within the heart are needed.
Improved systems, devices and methods for accessing a hollow organ, such as accessing the left atrium from the right atrium using a transseptal crossing, are provided herein by the way of exemplary embodiments. These embodiments are examples only and are not intended to limit the invention.
In one exemplary embodiment, a method for accessing a hollow organ, such as a left atrium, is provided, including: accessing the organ percutaneously; advancing a guidewire into the organ; advancing an elongate member having a delivery device along the guidewire into the organ, or for example into a right atrium for transseptal access to a left atrium; adjusting an orientation of the distal end of the delivery device from a first position to a variable second position, wherein the second position is in a desired orientation with respect to a target portion of the organ, such as an atrial septal wall, and is deflected away from the normal bias or a longitudinal axis of a proximal end of the elongate member; and using the delivery device to access and/or deliver other medical instruments to the organ, for performing one or more desired medical procedures on (or by way of) the organ. Optionally, another adjustment may be made to a distal end of an elongate member of the access system. Typically, these procedures are performed using imaging for guidance. In one embodiment, the method is used to create a transseptal puncture to facilitate a later medical treatment, such as ablation of abnormal tissue.
In one exemplary embodiment a system for accessing a left atrium is provided, including: an elongate member with a distal end and at least one inner lumen; an adjustment device configured to allow the orientation of the distal end of the elongate member to change from a first position to a variable second position, wherein the second position is in a desired orientation with respect to a septal wall and is deflected away from a longitudinal axis of a proximal end of the elongate member; and a puncture device housed at least partially within the inner lumen of the elongate member in a first configuration, wherein the puncture device optionally assumes an atraumatic second configuration upon advancement from the elongate member.
In another example embodiment, a delivery device is configured to be housed at least partially within the inner lumen of the elongate member in a first position; and the delivery device is advanceable through a first open region of the elongate member to a variable second position in a desired orientation to a septal wall, wherein the variable second position is external to the elongate member and deflected away from the elongate member; and a puncture device housed at least partially within an inner lumen of the delivery device in a first configuration, wherein the puncture device assumes an atraumatic second configuration upon advancement from the elongate member.
The foregoing is not an exhaustive list of embodiments. Other systems, methods, features and advantages of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the invention, and be protected by the accompanying claims. It is also intended that the invention is not limited to require the details of the example embodiments.
The details of the invention, both as to its structure and operation, may be gleaned in part by study of the accompanying figures, in which like reference numerals refer to like parts. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. Moreover, all illustrations are intended to convey concepts, where relative sizes, shapes and other detailed attributes may be illustrated schematically rather than literally or precisely.
Devices, systems and methods for accessing an internal hollow organ are described herein. For ease of discussion, these devices, systems and methods will be described with reference to transseptal access of a left atrium. However, it should be understood that these devices, systems and methods can be used to access a variety of hollow organs and to assist in delivery of a variety of medical instruments. In addition, one of skill in the art will readily recognize that the devices, systems and methods can be similarly applied to access the right atrium from the left atrium.
To facilitate description of the many alternative embodiments of access system 100, the anatomical structure of an example human heart will be described in brief.
It is desirable to gain access from one atrium to the other by passing a device through the atrial septal wall 207, i.e., a transseptal procedure. As will be described in more detail below, the transseptal procedure preferably includes inserting access system 100 into the vasculature of a patient and advancing an elongate body member 101 through the vasculature to inferior vena cava 202 (e.g., over a guidewire), from which access to right atrium 205 can be obtained. Once properly positioned within right atrium 205, system 100 can be used to deliver puncture device 103 to septal wall 207.
Elongate member 101 can be any of a variety of devices capable of insertion into a patient's (human or animal) vasculature, including but not limited to a hollow tubular member, such as a catheter. Access system 100 can also optionally include an adjustment device 105 (see
Any portion of access system 100 can optionally include an inter lumen exchange system 115. Inter lumen exchange system 115 allows the catheter, such as elongate member 101 (or delivery device 104, which is described later) to house multiple elongate devices. As mentioned, the one or more lumens 102 and 142 can be configured to house a variety of devices, such as puncture device 103, guidewire 111, pull wire 105, or other medical devices.
Here, lumen 102-A is aligned with common lumen 117 and lumen 102-B is offset from common lumen 117. This can facilitate the loading of components into member 101. For instance, loading the proximal end of a guidewire through distal end 112 of member 101 and into lumen 102-1 is made easier by aligning lumens 117 and 102-A and making it more difficult to accidentally load the guidewire proximal end into lumen 102-B, which may house a different component such as piercing structure 103.
Any variety of guidewires known in the art may be used, but a J-tip guidewire, such as a 0.035″ or 0.038″ is presently preferred. This embodiment also includes an optional deployable dilator 131. The distal region 110 of elongate member 101 includes distal end 112 and can be tapered to act as a dilator, and can be used alone or with an additional dilator extendable from within. Some embodiments may also facilitate dye injection, for instance, through open distal end 112 or another distal dye injection port communicating with a lumen 102, to aid in determining positioning. It should be noted that any number of lumens 102 can be provided and any type of treatment device can be received within each lumen 102, including, but not limited to a valvuloplasty device (e.g., balloons, etc.), a radio frequency (RF) ablation device, an imaging device, and the like. Elongate member 101 can also be used as a component within a larger catheter sheath.
In
As seen in
An exemplary method for transseptal left atrium access using the exemplary embodiments described with respect to
First, a patient's femoral vein (or other vasculature capable of being used to access right atrium 205) is accessed. Optionally, an introducer sheath is inserted into the selected vein. Next, a guidewire can be advanced through the sheath, and navigated through the patient's vascular system into the right atrium 205, preferably from the IVC through the right atrium and into the SVC. The guidewire can be used to guide additional components along the same path into right atrium 205.
More specifically, in one example, a needle is inserted into the femoral vein and a guidewire is advanced through the needle into that vein. The needle can then be removed and an access (or introducer) sheath can be routed over the guidewire. The access guidewire is preferably removed prior to inserting the guidewire used to access the heart. Typically, access to the heart is achieved with a J-tip guidewire, such as a 0.035″/0.038″ guidewire, which can be routed through the patient's vasculature into inferior vena cava 202 and then right atrium 205. The distal tip of this guidewire can be placed in the superior vena cava 203. The distal position of this guidewire can then be confirmed using imaging techniques. The confirmation of the positioning of the guidewire, as well as any desired portion of access system 100 throughout the procedure, can be accomplished from one or more of a variety of imaging techniques such as biplane fluoroscopy, pressure manometry, contrast infusion, transesophageal, intracardiac echocardiography, intravascular ultrasound, external ultrasound, or other imaging techniques. Any desired portion of access system 100 may also be composed of radiopaque materials to aid in determining positioning with fluoroscopy.
A proximal end of the guidewire can then be loaded into distal end 112 of elongate member 101. Elongate member 101 can then advanced through the introducer sheath and along the guidewire into the right atrium 205 or superior vena cava 203. The distal position of elongate member 101 can then be confirmed (again, using fluoroscopy or other imaging techniques). The guidewire can then be retracted at least partially into distal end 112 of elongate member 101, and preferably at about five (5) centimeters (cm) in from the distal end 112 of elongate member 101.
In an exemplary embodiment, the pre-biased distal end 112 is used in positioning with respect to the limbus 211. Alternatively, in embodiments without a pre-biased distal end 112, pull wire 105 can be used to introduce an amount of deflection into elongate member 101 to aid in positioning with respect to limbus 211. Elongate member 101 can then be retracted and adjusted as necessary so that distal end 112 is just inferior of the limbus 211. This can be accomplished using a “feel” technique where the physician (or other medical professional) retracts member 101 along septal wall 207 and uses tactile feedback to determine when distal end 112 passes over (or snaps over) limbus 211 (or alternatively, the physician can advance distal end 112 until it hits limbus 211 and stops further advancement, or the physician can use a combination of both advancement and retraction).
The deflection of distal end 112 of elongate member 101 can then be further deflected (if needed) using pull wire 105, for example, to achieve the desired orientation with respect to fossa ovalis 208.
If necessary, preferably continuing under imaging guidance, elongate member 101 can be rotated axially to assess the distension (or amount of dimpling or tenting) of the fossa ovalis 208 by distal end 112. Distension of the desired tissue is achieved by applying a force on the proximal end of access system 100. The degree of curvature in distal end 112, including its pre-bias and that introduced using pull wire 105, will impact the degree of distension. Generally, proper positioning of elongate member 101 is confirmed when the relative preferred amount of dimpling is achieved. A hole can then be created in septal wall 207 using puncture device 103. Preferably, puncture device 103 is an elongate piercing stylet that can be advanced through septal tissue, as depicted in
If distal region 110 of elongate member 101 (or device 104, described below) is tapered, it can be advanced into the hole in septal wall 207 to aid in dilating the hole. A separate elongate dilator 131 can also (or alternatively) be advanced from distal end 112 and through the septal opening to enlarge the hole. The deflected atraumatic distal portion 108 acts as a stop to further distal movement of the dilator or any other member advanced through the opening over puncture device 103. This acts to prevent inadvertent injury that would be caused should the dilator tip contact other structures in the left atrium (e.g., left atrial far wall, aorta, etc.). If desired, the atraumatic distal portion 108 can be retracted up against the septum primum prior to advancing dilator 131 (or other dilating portion or distal end) through the septal tissue. This acts to hold the distensible fossa ovalis 208 in position while the dilator widens the initial puncture site.
Next, puncture device 103 can be withdrawn, either partially inside or fully from elongate member 101. Finally, the guidewire can be advanced into left atrium 212. When the guidewire is in a desired position as confirmed using imaging techniques, pull wire 105 may be advanced, relaxing the tension and allowing elongate member 101 to adjust back toward its initial orientation. Access system 100 can then be retracted leaving the guidewire in left atrium 212.
Puncture device 103 may also include a retractable cover that, when retracted, allows the puncture device to assume its atraumatic shape. Puncture device 103 may also include an advancement control, such as a ratcheting mechanism. The ratcheting mechanism could be used to facilitate a controlled advancement or retraction of the puncture device 103. Proximal controller (described below) may be configured to control the advancement control of the puncture device, including through the ratcheting mechanism. In some embodiments, puncture device 103 may also be spring loaded, for deployment, retraction, or both.
The puncture device 103 or a portion thereof may comprise a flexible metal, a flexible polymer, or a combination thereof. A presently preferred flexible metal for the distal portion of the puncture device is NITINOL. NITINOL allows the puncture device to be deformed to fit within a flexible lumen and to change shape as necessary while carried within the elongate member (or delivery device) through the patient's vasculature, and then to transition to a previously set atraumatic shape upon puncturing a patient's tissue.
When configured as a piercing stylet, puncture device 103 can also include a piercing stylet assembly. The piercing stylet assembly can be housed, e.g., within one of the lumens of the dilator assembly. Although described here as an assembly, one can also implement the stylet as a monolithic device (e.g., with sections 108, 151 and 152 all being formed in one piece of material).
The piercing stylet has a relatively sharp distal end sufficient to pierce the intra-atrial septae tissue layers (septum primum and septum secundum). The piercing distal end can be constructed from a Nitinol wire or tube that has been sharpened. The atraumatic section 108 is distal to a tapered junction element 151 that allows a transition between diameters of the relatively narrow distal section and the relatively wider proximal section 152. The reduced profile distal section of the piercing stylet as well as the piercing distal tip 184 is heat treated to a preferred shape.
Tapered section (or junction element) 151 is connected to a tubular proximal section 152 that is housed within the catheter body and exits through the proximal controller handle. The outside diameter of proximal section 152 is approximately the same as the internal diameter of the common lumen 117 section within the dilator (or elongate member, delivery device or other member from which stylet 103 is deployed). These matched profiles create a near interference fit between stylet 103 and the surrounding assembly. Tapered section 151 possesses sufficient cross-sectional lumen space to enable a left atrial pressure measurement to be made by the user from the handle region. For example, tapered section 151 could possess a series of small holes 150 (e.g. circular, crescent) located circumferentially around section 150 that enables the user to measure left atrial pressure as shown in
Proximal section 152 of piercing stylet 103 can be constructed from a wire or a tube that is metal or plastic. If a tubular section is used, left atrial pressure can be measured from within the tube. If a wire is used, the blood pressure measurement is based on flow between the outside of the wire and the dilator lumen clearance.
After the pressure measurement is made, piercing stylet 103 can be retracted back into the double lumen section 115. Image guidance such as fluoroscopy can be used to facilitate the retraction of piercing stylet 103.
Here, puncture device is housed directly within an inner lumen of delivery device 104. Alternatively, a tubular dilator 131 can be housed immediately within delivery device 104, with puncture device 103 housed immediately within tubular dilator 131. In this and the other embodiments described herein, elongate member 101 generally refers to the large diameter catheter while delivery device 104 generally refers to a smaller diameter catheter deployable from within elongate member 101 and configured to deliver a treatment device (e.g., puncture device 103) or a diagnostic device.
An exemplary method for transseptal left atrium access using the exemplary embodiment of
Next, a proximal end of the guidewire 111 can be loaded into distal end 112 of elongate member 101. Elongate member 101 is then advanced along guidewire 111 into right atrium 205, and preferably from the IVC 202 through right atrium 205 and into the SVC 203, such that a distal end of access system 100 is in the SVC 203. The distal position of elongate member 101 can be confirmed using an imaging technique.
A hole can then be created in septal wall 207 with puncture device 103, such as by advancing a piercing stylet. Puncture device 103 preferably assumes an atraumatic shape after puncturing the patient's tissue and this can be confirmed using imaging techniques. If tapered, a distal region 113 of delivery device 104 can be advanced into the hole in the septal wall for dilation, and/or a separate dilator 131 can be advanced from distal end 114 into the hole. Then, puncture device 103 (see
Delivery device 104 is housed within a lumen in member 101, and exits that lumen at port 121. The portion of delivery device 104 between coupler 125 and port 121 is exposed. During lateral positioning of distal end 114 of delivery device 104, advancement of delivery device 104 distally with respect to elongate member 101 causes this portion to arc up or outwards, as illustrated in
Extension member 127 is rotatably coupled (or pivotably) with elongate member 101 and with coupler 125. This could include any rotatable coupling including but not limited to a pin, pivot, swivel-type hinge, or living hinge. Extension member 127 is shown here after being swung outwards (in a car door like fashion) along the X-Y plane to a position approximately perpendicular to elongate member 101, although it should be noted that this position is variable and can be less than or more than perpendicular. Extension member 127 allows delivery device 104 to move from a first position housed at least partially within (or alongside, in the case there is no channel) elongate member 101 to a second position, such that distal end 114 of delivery device 104 is external to elongate member 101 in the second position.
Here, it can be seen that coupler 125 is rotatably coupled with extension member 127 to provide two degrees of freedom. Extension member 127 is coupled to elongate member 101 with a swivel-type hinge 128 that allows extension member 127 to swing (or pivot) outwards. Hinge 128 is on a first end of extension member 127. On the second end of extension member 127 is hinge 129. Hinge 129 can be another swivel-type hinge and also allows delivery device 104 to swing (or pivot) laterally with respect to elongate member 101, again in the X-Y plane, while distal end 114 can continue to point distally in a direction generally (i.e., not necessarily exactly) parallel to the longitudinal axis 107 of elongate member 101.
Coupler 125 can be coupled with hinge 129 in at least two different ways. First, coupler 125 can be coupled with hinge 129 by way of a second hinge 130. Hinge 130 is configured to allow delivery device 104 to swing (or pivot) in the Z-Y and Z-X planes (depending on the degree of rotation of extension member 127 in the X-Y plane). This allows the rotation of the longitudinal axis of delivery device 104 with respect to longitudinal axis 107 of elongate member 101. Although two hinges 129-130 are used to provide this freedom of motion, it should be understood that other adjustable or articulatable (e.g., ball and socket) hinges/connectors or flexible connections can be provided such as to accomplish the functionality of both hinges 129 and 130.
In an alternative embodiment, coupler 125 can be secured or fixed to hinge 129, such as by way of a static (non-rotating) coupling, such as a cross-pin, also depicted as numeral 130. This is shown in more detail in the perspective view of FIG. SI. In this embodiment, extension member 127 is configured to flex (or twist), about its longitudinal axis 126, to allow delivery device 104 to swing (or pivot) along the Z-axis in the Z-Y and Z-X planes.
Extension member 127 is preferably formed from an elastic or superelastic material, such as NITINOL.
Further, open region 121, delivery device 104, and extension member 127, can be configured so that delivery device 104 and extension member 127 can deploy up, down, left or right with respect to the deflection of elongate member 101.
An exemplary method for transseptal left atrium access capable of use with the exemplary embodiments of
Next, a proximal end of a guidewire is loaded through distal end 112 of elongate member 101 and into a distal end 114 of delivery device 104. Member 101 is then advanced along the guidewire 111 into the right atrium 205, and preferably from the IVC through the right atrium and into the SVC, such that a distal end of access system 100 is in the SVC. The distal position of the elongate member 101 can be confirmed with an imaging technique such as fluoroscopy. Guidewire 111 can then be retracted through distal end 114 of delivery device 104 out of common lumen 117 and into a dedicated lumen 102. Next, access system 100 is retracted (proximally) from the SVC and positioned such that a distal end of the system is just inferior to the limbus. Preferably, system 100 is biased to curve towards the preferred location for puncture on the septal wall (e.g., via heat-treatment), allowing system 100 to be directed against the fossa ovalis. Alternatively, the adjustment device 105 (e.g., pull wire, etc.) is used to deflect access system 100 into the preferred location. This can be accomplished by deflecting elongate member 101 with adjustment device 105, in addition to any needed retraction, advancement or rotation of elongate member 101. Proper positioning is then confirmed with an imaging technique. Identification of the limbus and/or identification of any tenting, or dimpling, of the fossa ovalis can be used to help confirm proper positioning.
Next the orientation of distal end 114 of delivery device 104 is adjusted to a desired orientation with respect to septal wall 207. If an extension member 127 is included, this includes using the extension member 127 to position distal end 114 of the delivery device away from the elongate member 101 as shown in
All embodiments may include a dilator 131. The dilator 131 may be extended (as shown in
Referring back to the method example, dilator 131 can then be optionally advanced from delivery device 104 into the fossa ovalis 208. Tenting, or dimpling, of the fossa ovalis 208 by dilator 131 can be confirmed through one of the aforementioned imaging techniques. A hole is then created in the septal wall 207. Typically this is accomplished using puncture device 103. Also, as described above the puncture device 103 typically assumes an atraumatic shape after puncturing the patient's tissue. (
Finally, dilator 131 can be retracted back into delivery device 104 (see
Each embodiment preferably includes puncture device 103, or another apparatus for creating a hole in a patient's tissue. Puncture device 103 can comprise one or more of a variety of devices known in the art, including but not limited to solid or hollow needles, a Brockenbrough needle, a piercing stylet, or a sharpened guidewire. Alternatively puncture device 103 could use radio frequency ablation, optical energy, thermal energy, and the like. The puncture device 103 may be straight or curved, rigid or flexible, or may include a combination thereof. The puncture device 103 may be configured to be slidably housed at least partially within an inner lumen of the elongate member 101, delivery device 104, and/or within a dilator 131 attached to either elongate member 101 or delivery device 104.
Optionally, a distal portion of puncture device 103 may further be configured or biased such that it assumes an atraumatic shape upon puncturing the patient's tissue, such as after puncturing a septal wall during a transseptal crossing. The atraumatic shape is preferably configured such that it minimizes the risk of trauma to surrounding tissue, such as an aorta or left atrial far wall. A variety of shapes can be used.
In conventional systems, left heart access through the fossa ovalis is not performed in a relatively controlled or precise manner, resulting in punctures that are not in the preferred location. Puncture location has become increasingly more important through advancements made in structural heart interventions.
For example, patients that are treated for atrial fibrillation may have their left atrial appendage closed. Closure of the atrial appendage can be performed via a percutaneous access to the femoral vein and transseptal puncture. However, when performing transseptal puncture for closing the left atrial appendage (LAA), it is sometimes preferred to puncture the septum superiorly. It may be even more advantageous to puncture the septum on the posterior side as well as superiorly. A posterior-superior puncture aligns the treatment device for preferred access to the LAA. This puncture location may be considered safer as it would be further away from the aorta. The embodiments described with respect to
A second example of a left heart interventional procedure that prefers a posterior superior puncture would be mitral valve edge-to-edge repair. In order to enter the valve in a perpendicular manner, the treatment device has to be properly aligned about the valve. The preferred alignment is achieved when the puncture location is performed in the PS position.
The physician may also desire to puncture the fossa ovalis in the anterior position. A device that facilitates anterior puncture in a safe manner would be advantageous.
The distance from the main axis 107 of elongate member 101 (catheter body) is a variable that must be taken into consideration. For example, in a patient with a large fossa, it may be desirable to puncture 6 to 8 mm from the catheter axis and preferably 7 mm. In a patient with a small fossa it may be desirable to puncture at 4 or 5 mm. Achieving different puncture locations can be accomplished with different lengths of extension member 127, different degrees of allowable rotation and/or with a device where the pivot point is adjustable.
Due to the variation of heart anatomy such as overall heart size, right and left atrial size, heart rotation and tissue thickness as well as histologic and pathologic conditions it may be advantageous to puncture the fossa in a variety of locations. For example, with a smaller heart that is rotated, it may be desired to puncture the septum primum posteriorly or inferiorly. The physician can determine, with use of imaging guidance prior to the procedure, where the desired location for puncture is in advance of the procedure. However, the physician may not be able to determine the puncture location prior to the procedure and, therefore, may want to decide where to puncture once access to the right atrium is achieved.
Based on the description herein, it is possible to puncture the septal wall at one, two, three, four, five, seven, eight, nine, ten, eleven or twelve o'clock positions. For purposes herein, these positions are each defined as a 30 degree window (e.g., two o'clock is from 31-60 degrees about the central area of fossa ovalis 208, while ten o'clock is from 271-300 degrees about the central area). A two o'clock anterior superior position would be in the two o'clock position over the AS portion of the septal wall, which, unless specified otherwise, can be within the fossa ovalis or just outside the fossa ovalis.
Extension member 127 can also be configured to swing either to the left or the right of elongate member 101 as opposed to being fixed to deploy to only one of the two sides.
Turning back to a method of used, although there are many different implementations and variations of method, for ease of discussion, method will be described herein using an exemplary embodiment of access system 100 having puncture device 103, delivery device 104, and adjustment device 105.
The devices and methods herein may be used in any part of the body, in order to treat a variety of disease states. Of particular interest are applications within hollow organs including but not limited to the heart and blood vessels (arterial and venous), lungs and air passageways, digestive organs (esophagus, stomach, intestines, biliary tree, etc.). The devices and methods will also find use within the genitourinary tract in such areas as the bladder, urethra, ureters, and other areas.
One exemplary method for accessing a hollow organ other than the left atrium includes: accessing the organ percutaneously; advancing a guidewire 111 into the organ; advancing an elongate member 101 having a delivery device 104 along the guidewire 111 into the organ; optionally retracting the guidewire 111 at least partially into the delivery device 104 or elongate member 101; adjusting an orientation of the distal end of the delivery device 104 from a first position to a variable second position, wherein the second position is in a desired orientation with respect to a desired portion of the organ and is deflected away from the normal bias of a proximal end of the elongate member; and using the delivery device 104 to perform a desired medical procedure on the organ.
Furthermore, access system 100 may be used to pierce tissue and/or deliver medication, fillers, toxins, and the like in order to offer benefit to a patient. For instance, the device could be used to deliver bulking agent such as collagen, pyrolytic carbon beads, and/or various polymers to the urethra to treat urinary incontinence and other urologic conditions or to the lower esophagus/upper stomach to treat gastroesophageal reflux disease. Alternatively, the devices could be used to deliver drug or other agent to a preferred location or preferred depth within an organ. For example, various medications could be administered into the superficial or deeper areas of the esophagus to treat Barrett's esophagus, or into the heart to promote angiogenesis or myogenesis. Alternatively, the off-axis system can be useful in taking biopsies, both within the lumen and deep to the lumen. For example, the system could be used to take bronchoscopic biopsy specimens of lymph nodes that are located outside of the bronchial tree or flexible endoscopic biopsy specimens that are located outside the gastrointestinal tract. The above list is not meant to limit the scope of the invention.
In some embodiments, access system 100 is used with an anchoring means in order to anchor the device to a location within the body prior to rotation of the off-axis system described with respect to
Control of access system 100 can be accomplished with the use of a proximal control device, or proximal controller.
While the invention is susceptible to various modifications and alternative forms, a specific example thereof has been shown in the drawings and is herein described in detail. It should be understood, however, that the invention is not to be limited to the particular form disclosed, but to the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit of the disclosure. As used herein, the terms “exemplary” and “example” are interchangeable.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US11/27320 | 3/4/2011 | WO | 00 | 8/7/2013 |
Number | Date | Country | |
---|---|---|---|
61310445 | Mar 2010 | US |